Form 4: Paul Rosenbaum Reports Significant Increase in ParkerVision Inc. Holdings Through Convertible Note Conversions
SEC Form 4 Filing
Director Paul Rosenbaum increased his holdings in ParkerVision Inc. through the conversion of convertible notes into common stock, as reported in a recent SEC filing.
Summary
- Paul Rosenbaum, a director of ParkerVision Inc., filed a Form 4 with the SEC detailing changes in his beneficial ownership of the company's stock.
- On October 29, 2024, Rosenbaum converted two convertible notes into common stock.
- The first conversion involved a note dated May 10, 2022, with a face value of $100,000 and a conversion price of $0.13, resulting in the issuance of 816,924 shares.
- The second conversion involved a note dated September 15, 2023, with a face value of $100,000 and a conversion price of $0.25, resulting in the issuance of 435,467 shares.
- On December 31, 2024, Rosenbaum received 11,765 shares as interest in kind on the May 10, 2022 convertible note at a price of $0.17.
- Following these transactions, Rosenbaum's total direct holdings in ParkerVision Inc. common stock increased to 1,859,796 shares as of October 29, 2024, before decreasing to 607,405 shares as of December 31, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing simply reports transactions and doesn't inherently indicate positive or negative news about the company's performance.
Positives
- The conversion of convertible notes into common stock could be seen as a positive signal, indicating Rosenbaum's confidence in the company's future prospects.
Risks
- The conversion of convertible notes dilutes existing shareholders' equity.
- The filing does not provide insight into the company's overall financial health or strategic direction.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The conversion of debt into equity can be a common financial strategy, but its impact depends on the company's specific circumstances and overall financial health.
Stakeholder Impact
- Shareholders may experience dilution due to the issuance of new shares upon conversion of the notes.
Key Dates
| Date | Description |
|---|---|
| 05/10/2022 | Date of the first convertible note, with a face value of $100,000 and a conversion price of $0.13. |
| 09/15/2023 | Date of the second convertible note, with a face value of $100,000 and a conversion price of $0.25. |
| 10/29/2024 | Date of the convertible note conversions into common stock. |
| 10/31/2024 | Date of Paul Rosenbaum's signature on the Form 4 filing. |
| 12/31/2024 | Date of interest in kind payment on Convertible Note dated May 10, 2022. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.